Related Experiment Videos
Blocked Ras activation in anergic CD4+ T cells
P E Fields1, T F Gajewski, F W Fitch
1Ben May Institute, Department of Pathology, University of Chicago, IL 60637, USA.
Science (New York, N.Y.)
|March 1, 1996
Summary
T cell anergy prevents interleukin-2 (IL-2) production by blocking the Ras signaling pathway. This defect in Ras activation selectively shuts down IL-2 production in anergic T cells.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- T cell anergy is a critical mechanism of immune tolerance.
- Functional unresponsiveness in T cells is marked by impaired interleukin-2 (IL-2) production.
Purpose of the Study:
- To investigate the molecular mechanisms underlying T cell anergy.
- To identify the specific signaling pathway defects responsible for the unresponsiveness in anergic T cells.
Main Methods:
- Stimulation of anergic murine T helper cell 1 clones.
- Analysis of mitogen-activated protein kinases (ERK-1/ERK-2) and p21ras activation.
- Assessment of Shc, Grb-2, and Son of Sevenless complex formation and phosphorylation.
Main Results:
- Anergic T cells failed to activate ERK-1/ERK-2 and p21ras upon T cell receptor stimulation.
- The block in Ras activation was not due to defects in Shc, Grb-2, or Son of Sevenless association or phosphorylation.
- This Ras pathway impairment may lead to defective transactivation at activator protein 1 sites.
Conclusions:
- The Ras signaling pathway is a key target for T cell anergy induction.
- Defective Ras activation selectively inhibits IL-2 production, contributing to immune tolerance.
- Understanding this pathway is crucial for developing strategies to modulate T cell responses.